Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics

Current management of low-grade gliomas

(2016) Andreas F. Hottinger et al.   CURRENT OPINION IN NEUROLOGY

Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma

(2016) Changho Choi et al.   JOURNAL OF CLINICAL ONCOLOGY

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

(2016) Brigitta G Baumert et al.   LANCET ONCOLOGY

Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials

(2016) Edward K. Avila et al.   NEURO-ONCOLOGY

Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide

(2016) Michael Wahl et al.   NEURO-ONCOLOGY

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

(2016) Jan C. Buckner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Characteristics of gliomas in patients with somatic IDH mosaicism

(2016) Charlotte Bonnet et al.   Acta Neuropathologica Communications

Kinetic evaluation of low-grade gliomas in adults before and after treatment with CCNU alone

(2015) Gentian Kaloshi et al.   JOURNAL OF NEUROSURGERY

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma

(2015) Julia Furtner et al.   NEURO-ONCOLOGY

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics

(2014) Walter Taal et al.   JOURNAL OF NEURO-ONCOLOGY

Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas

(2014) C. Goze et al.   NEURO-ONCOLOGY

Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy

(2013) F. Ducray et al.   JOURNAL OF NEURO-ONCOLOGY

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas

(2013) Johan Pallud et al.   NEURO-ONCOLOGY

Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma

(2013) B. E. Johnson et al.   SCIENCE

Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas

(2012) J. Pallud et al.   NEURO-ONCOLOGY

Quantitative Morphological Magnetic Resonance Imaging Follow-up of Low-Grade Glioma

(2012) Johan Pallud et al.   NEUROSURGERY

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

(2011) MJ van den Bent et al.   LANCET ONCOLOGY

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

(2011) A. B. Lassman et al.   NEURO-ONCOLOGY

Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas

(2010) M. Peyre et al.   NEURO-ONCOLOGY

Chemotherapy for low-grade gliomas: When? How? How long?

(2010) M. Weller   NEURO-ONCOLOGY

NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

(2009) Wolfgang Wick et al.   JOURNAL OF CLINICAL ONCOLOGY

Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up

(2009) Linda Douw et al.   LANCET NEUROLOGY

Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection

(2009) Emmanuel Mandonnet et al.   NEUROSURGICAL REVIEW